文献速递临床试验与 GCP基础与转化研究

粪菌移植对溃疡性结肠炎回肠储袋肛管吻合术后慢性复发性储袋炎的影响:前瞻性多中心双盲随机对照试验方案

Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
PubMed 文献 · Trials · 2020-06-03

约15%的溃疡性结肠炎患者需行直肠结肠切除加回肠储袋肛管吻合术,其中约50%会发生储袋炎,约10%转为慢性且缺乏有效治疗。

要点

  • 约15%的溃疡性结肠炎患者需行回肠储袋肛管吻合术。
  • 术后约50%发生储袋炎,其中约10%转为慢性且治疗选择极少。
  • 研究比较粪菌移植与假移植延缓慢性复发性储袋炎复发。

核心结论

  • 研究旨在比较粪菌移植与假移植对慢性复发性储袋炎复发的延缓作用,目前尚无结果结论。

研究设计与样本

  • 对抗生素治疗有应答的患者按1:1随机接受粪菌移植或假移植。

关键数值与推荐

  • 约15%的溃疡性结肠炎患者需行直肠结肠切除加回肠储袋肛管吻合术。
  • 约50%的患者会发生储袋炎,约10%的病例储袋炎症转为慢性。

临床怎么用

  • 若研究结果确证有效,粪菌移植因费用低于生物制剂,未来可能成为常规治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Almost 15% of patients with ulcerative colitis (UC) will require a proctocolectomy with ileal pouch-anal anastomosis (IPAA) as a result of fulminant colitis, dysplasia, cancer, or medical refractory diseases. Around 50% will experience pouchitis, an idiopathic inflammatory condition involving the ileal reservoir, responsible for digestive symptoms, deterioration in quality of life, and disability. Though the majority of initial cases of pouchitis are easily managed with a short course of antibiotics, in about 10% of cases, inflammation of the pouch becomes chronic with very few treatments available. Previous studies have suggested that manipulating the composition of intestinal flora through antibiotics, probiotics, and prebiotics achieved significant results for treating acute episodes of UC-associated pouchitis. However, there is currently no established effective treatment for chronic antibiotic-dependent pouchitis. Fecal microbiota transplantation (FMT) is a novel therapy involving the transfer of normal intestinal flora from a healthy donor to a patient with a medical condition potentially caused by the disrupted homeostasis of intestinal microbiota or dysbiosis. METHODS: Our project aims to compare the delay of relapse of chronic recurrent pouchitis after FMT versus sham transplantation. Forty-two patients with active recurrent pouchitis after having undergone an IPAA for UC will be enrolled at 12 French centers. The patients who respond to antibiotherapy will be randomized at a ratio of 1:1 to receive either FMT or sham transplantation. DISCUSSION: On April 30, 2014, the World Health Organization published an alarming report on antibiotic resistance. Finding an alternative medical treatment to antibiotics in order to prevent relapses of pouchitis is therefore becoming increasingly important given the risk posed by multiresistant bacteria. Moreover, if the results of this study are conclusive, FMT, which is less expensive than biologics, could become a routine treatment in the future. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03524352. Registered on 14 May 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Trang-Poisson C, Kerdreux E, Poinas A, et al. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials. 2020. PMID: 32493442. doi:10.1186/s13063-020-04330-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。